Study to Test the Possibility of Cross Reaction of the Antibodies Induced by the ELAPRASE (R) to GSK2788723 ELAPRASE is a Trade Mark Owned by a Third Party
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Idursulfase (Primary)
- Indications Mucopolysaccharidosis II
- Focus Pharmacodynamics
- Sponsors GSK
Most Recent Events
- 09 May 2014 New trial record